SETD2 and prostate cancer: Therefore, to determine whether HIF-1 expression plays a role in COX-2 transcriptional activation, PC-3 prostate cancer cells were transfected with a COX-2 promoter reporter containing a 960-bp human COX-2 promoter with the potential HIF-1 binding site.